Cite
HARVARD Citation
Shatzer, A. et al. (2017). Ganetespib, an HSP90 inhibitor, kills Epstein–Barr virus (EBV)-infected B and T cells and reduces the percentage of EBV-infected cells in the blood. Leukemia & lymphoma. 58 (4), pp. 923-931. [Online].